VIATRIS

88607510 | Trademark

Interested in this case?

Request a Demo Track this case, and find millions of cases like it, let us show you how.
Filed Sept. 6, 2019
Serial No. 88607510
Examining Attorney BIANCA ALLEN
Class Pharmaceutical preparations for the treatment of cardiovascular, gastrointestinal, neurological, respiratory, psychiatric, allergic, dermatological, pulmonary, metabolic, muscular, erectile dysfunction, infectious and inflammatory conditions, cancer, diabetes, multiple sclerosis; oral and transdermal contraceptives; 006; 018; 044; 046; 051; 052; 026; 039; 044
VIATRIS
Case Type Trademark
Status Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Opposition 88607510
TRIS PHARMA, INC v. Mylan Inc.
  • Mylan Inc.;
  • TRIS PHARMA, INC;
Last Updated: 1 month, 1 week ago
Filing Date # Docket Text
9/19/2023
9/18/2023
9/18/2023ABANDONMENT - NO USE STATEMENT FILED
9/18/2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
2/16/2023
2/16/2023
2/16/2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2/15/2023SOU EXTENSION 5 GRANTED
2/9/2023
2/9/2023SOU TEAS EXTENSION RECEIVED
2/9/2023SOU EXTENSION 5 FILED
8/30/2022
8/30/2022
8/30/2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
8/29/2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
8/29/2022SOU EXTENSION 4 GRANTED
8/17/2022
8/17/2022SOU TEAS EXTENSION RECEIVED
8/17/2022SOU EXTENSION 4 FILED
2/16/2022
2/16/2022
2/16/2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2/14/2022
2/14/2022SOU TEAS EXTENSION RECEIVED
2/14/2022SOU EXTENSION 3 FILED
2/14/2022SOU EXTENSION 3 GRANTED
8/13/2021
8/13/2021
8/13/2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
8/11/2021
8/11/2021SOU TEAS EXTENSION RECEIVED
8/11/2021SOU EXTENSION 2 FILED
8/11/2021SOU EXTENSION 2 GRANTED
2/16/2021
2/16/2021
2/16/2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
2/12/2021
2/12/2021SOU TEAS EXTENSION RECEIVED
2/12/2021SOU EXTENSION 1 FILED
2/12/2021SOU EXTENSION 1 GRANTED
8/18/2020
8/18/2020
8/18/2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
7/2/2020EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
6/30/2020
6/30/2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
6/30/2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
6/30/2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
1/27/2020
1/27/2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
1/27/2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
1/23/2020EXTENSION OF TIME TO OPPOSE RECEIVED
1/23/2020TTAB Proceeding Filed: TRIS PHARMA, INC v. Mylan Inc., 88607510
12/24/2019
12/24/2019PUBLISHED FOR OPPOSITION
12/24/2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/4/2019
12/4/2019
12/4/2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/16/2019
11/15/2019
11/15/2019
11/15/2019APPROVED FOR PUB - PRINCIPAL REGISTER
11/14/2019ASSIGNED TO EXAMINER
9/18/2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
9/10/2019NEW APPLICATION ENTERED
9/6/2019
9/6/2019